-+ 0.00%
-+ 0.00%
-+ 0.00%

Arrowhead Pharmaceuticals To Present Data On Plozasiran In Patients With Severe Hypertriglyceridemia At European Society Of Cardiology Congress

Benzinga·08/24/2026 11:31:23
语音播报

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it will present important new data at the European Society of Cardiology Congress (ESC) in Munich, Germany.